|
CHINESE vaccines for Hepatitis A will be exported for the first time to India, marking a breakthrough for the communist nation's biotechnology sector.
Live Hepatitis A vaccine made by the Zhejiang Pukang Biotech Co, based in Hangzhou, capital of east China's Zhejiang Province has been given a green light to enter the Indian market, marking a debut export of China-made vaccines.
The vaccines independently developed by Chinese virologists have been inoculated on 130 million persons in China, which has helped bring down the incidence of the infectious disease by 20 per cent every year in China during the past decade.
The Zhejiang Pukang Biotech Co. said the vaccines with complete domestic intellectual property right were ready for export to India, after they passed human test and the ensuing observation for three years in the country, Xinhua news agency reported recently.
Although China announced that it has basically controlled the prevalence of Hepatitis A, there are still 1.4 million people found infected with the disease globally.
Vaccines remain the most effective way to curb the spreading of Hepatitis diseases. Pukang Biotech is exploring exports of the vaccines to Guatemala and the Philippines.
|